Abstract:Abstract Background Breast cancer (BC) is a complex disease with high heterogeneity, which often leads to great differences in treatment results. Current common molecular typing method is PAM50, which shows positive results for precision medicine; however, room for improvement still remains because of the different prognoses of subtypes. Therefore, in this article, we used lncRNAs, which are more tissue-specific and developmental stage-specific than other RNAs, as typing markers and combined single-cell expression profiles to retype BC, to provide a new method for BC classification and explore new precise therapeutic strategies based on this method. Methods Based on lncRNA expression profiles of 317 single cells from 11 BC patients, SC3 was used to retype BC, and differential expression analysis and enrichment analysis were performed to identify biological characteristics of new subtypes. The results were validated for survival analysis using data from TCGA. Then, the downstream regulatory genes of lncRNA markers of each subtype were searched by expression correlation analysis, and these genes were used as targets to screen therapeutic drugs, thus proposing new precision treatment strategies according to the different subtype compositions of patients. Results Seven lncRNA subtypes and their specific biological characteristics are obtained. Then, 57 targets and 210 drugs of 7 subtypes were acquired. New precision medicine strategies were proposed according to the different compositions of patient subtypes. Conclusions For patients with different subtype compositions, we propose a strategy to select different drugs for different patients, which means using drugs targeting multi subtype or combinations of drugs targeting a single subtype to simultaneously kill different cancer cells by personalized treatment, thus reducing the possibility of drug resistance and even recurrence.

Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data

Leveraging Single-Cell Sequencing to Classify and Characterize Tumor Subgroups in Bulk RNA-Sequencing Data

A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data

P02.05 Comprehensive Profiling of Tumor Heterogeneity and Its Microenvironment in Advanced Non-Small Cell Lung Cancer at Single Cell Resolution

Prudent Application of Single-Cell RNA Sequencing in Understanding Cellular Features and Functional Phenotypes in Cancer Studies

Using Single‐cell Multiple Omics Approaches to Resolve Tumor Heterogeneity

Single-cell sequencing technology in tumor research

Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing

Application and prospects of single cell sequencing in tumors

Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq

Applications of single-cell sequencing in cancer research: progress and perspectives

Single-Cell Analysis in Cancer Genomics

Single-cell transcriptomics in cancer: computational challenges and opportunities

Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing

Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level

Identification of distinct tumor cell patterns with single-cell RNA sequencing integrating primary lung adenocarcinoma and brain metastasis tumor

Unraveling tumor heterogeneity: Quantitative insights from scRNA-seq analysis in breast cancer subtypes

Application of single-cell sequencing in human cancer

Single-Cell Multimodal Analytical Approach by Integrating Raman Optical Tweezers and RNA Sequencing

Single-cell dissection of transcriptional heterogeneity in human colon tumors

Single-cell multi-omics sequencing and its application in tumor heterogeneity.